Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rook

Showing results (111-120 of 187) with videos related to

Pageof 19
Sort By:
The New England Journal of Medicine|July 1, 1982
Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipientsG V Quinnan, N Kirmani, A H Rook, et al.
Blood Advances|September 2, 2022
TCRvβ-CART therapy mediates high-precision targeting of malignant T-cell clonesLauren C Shaw, Mathilde Poussin, Alba Rodriguez-Garcia, et al.
Bone Marrow Transplantation|October 16, 2002
Identification of amplified clonal T cell populations in the blood of patients with chronic graft-versus-host disease: positive correlation with response to photopheresisL E French, T Alcindor, M Shapiro, et al.
Cutis|October 26, 2020
Cutaneous T-cell lymphoma and concomitant atopic dermatitis responding to dupilumabNicholas K Mollanazar, Kevin T Savage, Bobak T Pousti, et al.
Journal of the American Academy of Dermatology|February 6, 2008
Total skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndromeCamille E Introcaso, Bizhan Micaily, Stephen K Richardson, et al.
Journal of the American Academy of Dermatology|December 1, 1996
Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institutionS L Gottlieb, J T Wolfe, F E Fox, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1986
Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsivenessA H Rook, J H Kehrl, L M Wakefield, et al.
Dermatologic Therapy|April 28, 2022
Management of relapsed cutaneous T-Cell lymphoma following allogeneic hematopoietic stem cell transplantation: Review with representative patient caseDavid M Weiner, Daniel J Lewis, Natalie G Spaccarelli, et al.
Leukemia & Lymphoma|September 28, 2011
Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphomaMaria Wysocka, Noor Dawany, Bernice Benoit, et al.
The American Journal of Medicine|May 1, 1985
Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parametersE P Gelmann, O T Preble, R Steis, et al.
Pageof 19

Showing results (111-120 of 187) with videos related to

Sort By:
Pageof 19
The New England Journal of Medicine|July 1, 1982
Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipientsG V Quinnan, N Kirmani, A H Rook, et al.
Blood Advances|September 2, 2022
TCRvβ-CART therapy mediates high-precision targeting of malignant T-cell clonesLauren C Shaw, Mathilde Poussin, Alba Rodriguez-Garcia, et al.
Bone Marrow Transplantation|October 16, 2002
Identification of amplified clonal T cell populations in the blood of patients with chronic graft-versus-host disease: positive correlation with response to photopheresisL E French, T Alcindor, M Shapiro, et al.
Cutis|October 26, 2020
Cutaneous T-cell lymphoma and concomitant atopic dermatitis responding to dupilumabNicholas K Mollanazar, Kevin T Savage, Bobak T Pousti, et al.
Journal of the American Academy of Dermatology|February 6, 2008
Total skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndromeCamille E Introcaso, Bizhan Micaily, Stephen K Richardson, et al.
Journal of the American Academy of Dermatology|December 1, 1996
Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institutionS L Gottlieb, J T Wolfe, F E Fox, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1986
Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsivenessA H Rook, J H Kehrl, L M Wakefield, et al.
Dermatologic Therapy|April 28, 2022
Management of relapsed cutaneous T-Cell lymphoma following allogeneic hematopoietic stem cell transplantation: Review with representative patient caseDavid M Weiner, Daniel J Lewis, Natalie G Spaccarelli, et al.
Leukemia & Lymphoma|September 28, 2011
Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphomaMaria Wysocka, Noor Dawany, Bernice Benoit, et al.
The American Journal of Medicine|May 1, 1985
Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parametersE P Gelmann, O T Preble, R Steis, et al.
Pageof 19